Clinical Trials Co-ordinator (Regulatory Affairs)
Under the leadership of our Chief Executive, Professor Paul Workman FRS, the ICR is ranked as the UK’s leading academic research centre. Together with our partner The Royal Marsden, we are rated in the top five cancer centres globally.
The ICR is committed to attracting, developing and retaining the best minds in the world to join us in our mission – to make the discoveries that defeat cancer.
We are looking for an experienced, dynamic and effective Clinical Trials Co-Ordinator for Regulatory Affairs to work within the Prostate Cancer Targeted Therapy Team, which undertakes early clinical trials of new anticancer drugs. We are a rapidly expanding, internationally leading clinical trials unit, based on a dedicated ward within the Royal Marsden Hospital, for the development of novel cancer therapeutics, which we believe will improve the care of prostate cancer patients.
The post holder will have relevant clinical trials experience and knowledge of GCP standards and trial related regulatory requirements. The post involves the conduct of regulatory affairs for the Prostate Cancer Targeted Therapy Team. Microsoft Office skills are essential. Unsupervised experience with clinical trial regulatory submissions is necessary. Knowledge of Phase 1, 2 and 3 clinical trials study setup for patients with Prostate Cancer is desirable.
Starting salary will be on the HSO scale (£32,000). This post benefits from generous annual leave entitlement and a defined benefit pension scheme. Appointments will be on a one-year contract in the first instance.
To apply please submit online application on the ICR Careers site, attaching your CV with the supporting statement (addressing with specific examples where you meet the person specification, a brief description of your research experience and incl. the names and addresses of at least two referees).
For more details, please refer to the job description and person specification.
If you are an EU citizen please see the below link for further information about Brexit:
This Program is closed to applications.